VYDAPTIV BIOPHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Nov 2017)
What this means for you
This application is over — abandoned 20 Nov 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86758044
- Mark type
- Stylized text
- Filed
- 16 Sept 2015
- Published for opposition
- 23 Feb 2016
- Abandoned
- 20 Nov 2017
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, cancer and immune system diseases and disorders, auto immune system diseases, and blood disorders
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- APTEVO THERAPEUTICS INC., SEATTLE, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
Prosecution history
- 20 Nov 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 20 Nov 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Apr 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Apr 2017 — SOU EXTENSION 2 GRANTED
- 18 Apr 2017 — SOU EXTENSION 2 FILED
- 18 Apr 2017 — SOU TEAS EXTENSION RECEIVED
- 05 Apr 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Oct 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Oct 2016 — SOU EXTENSION 1 GRANTED
- 18 Oct 2016 — SOU EXTENSION 1 FILED
- 18 Oct 2016 — SOU TEAS EXTENSION RECEIVED
- 18 May 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Apr 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Feb 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Feb 2016 — PUBLISHED FOR OPPOSITION